These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25746592)

  • 21. Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.
    Yang SL; Ren QG; Wen L; Hu JL
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):321-327. PubMed ID: 27376798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF; Zahran AM; El-Mahdy RI; Nabil EE; Esmaeel HM; Elkady OA; Elkady A; Mohareb DA; Mahmoud Mostafa M; John J
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1927-1933. PubMed ID: 31244320
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD24, a novel cancer biomarker, predicting disease-free survival of non-small cell lung carcinomas: a retrospective study of prognostic factor analysis from the viewpoint of forthcoming (seventh) new TNM classification.
    Lee HJ; Choe G; Jheon S; Sung SW; Lee CT; Chung JH
    J Thorac Oncol; 2010 May; 5(5):649-57. PubMed ID: 20354454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent epigenetic inactivation of deleted in lung and esophageal cancer 1 gene by promoter methylation in non-small-cell lung cancer.
    Zhang Y; Miao Y; Yi J; Wang R; Chen L
    Clin Lung Cancer; 2010 Jul; 11(4):264-70. PubMed ID: 20630829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of MicroRNA-221 is associated with poor prognosis in non-small cell lung cancer patients.
    Zhang Y; Zhao Y; Sun S; Liu Z; Zhang Y; Jiao S
    Tumour Biol; 2016 Aug; 37(8):10155-60. PubMed ID: 26831656
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer.
    Yin QW; Sun XF; Yang GT; Li XB; Wu MS; Zhao J
    Int J Clin Exp Pathol; 2015; 8(1):842-6. PubMed ID: 25755784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
    J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of microRNA-10b overexpression in peripheral blood mononuclear cells of nonsmall-cell lung cancer patients.
    Yang YL; Xu LP; Zhuo FL; Wang TY
    Tumour Biol; 2015 Sep; 36(9):7069-75. PubMed ID: 25869877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum lemur tyrosine kinase-3: a novel biomarker for screening primary non-small cell lung cancer and predicting cancer progression.
    Zhang K; Chen L; Deng H; Zou Y; Liu J; Shi H; Xu B; Lu M; Li C; Jiang J; Wang Z
    Int J Clin Exp Pathol; 2015; 8(1):629-35. PubMed ID: 25755755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-148b is down-regulated in non-small cell lung cancer and associated with poor survival.
    Ge H; Li B; Hu WX; Li RJ; Jin H; Gao MM; Ding CM
    Int J Clin Exp Pathol; 2015; 8(1):800-5. PubMed ID: 25755777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Status of the Parkinson's disease gene family expression in non-small-cell lung cancer.
    Liu QX; Zheng H; Deng XF; Zhou D; Dai JG
    World J Surg Oncol; 2015 Aug; 13():238. PubMed ID: 26245297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An immunohistochemical study of cyclin-dependent kinase 5 (CDK5) expression in non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC): a possible prognostic biomarker.
    Wei K; Ye Z; Li Z; Dang Y; Chen X; Huang N; Bao C; Gan T; Yang L; Chen G
    World J Surg Oncol; 2016 Feb; 14(1):34. PubMed ID: 26860827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferential Localization of MET Expression at the Invasion Front and in Spreading Cells Through Air Spaces in Non-Small Cell Lung Carcinomas.
    Lapère C; Cortot AB; Grégoire V; Cockenpot V; Tulasne D; Copin MC
    Am J Surg Pathol; 2017 Mar; 41(3):414-422. PubMed ID: 28098570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low serum miR-98 as an unfavorable prognostic biomarker in patients with non-small cell lung cancer.
    Wang K; Dong L; Fang Q; Xia H; Hou X
    Cancer Biomark; 2017 Sep; 20(3):283-288. PubMed ID: 28946561
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyr1068-phosphorylated epidermal growth factor receptor (EGFR) predicts cancer stem cell targeting by erlotinib in preclinical models of wild-type EGFR lung cancer.
    Sette G; Salvati V; Mottolese M; Visca P; Gallo E; Fecchi K; Pilozzi E; Duranti E; Policicchio E; Tartaglia M; Milella M; De Maria R; Eramo A
    Cell Death Dis; 2015 Aug; 6(8):e1850. PubMed ID: 26247735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
    Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
    Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical implications of high MET gene dosage in non-small cell lung cancer patients without previous tyrosine kinase inhibitor treatment.
    Chen YT; Chang JW; Liu HP; Yu TF; Chiu YT; Hsieh JJ; Chen YT; Chen YR; Wu HD; Huang SF
    J Thorac Oncol; 2011 Dec; 6(12):2027-35. PubMed ID: 22052229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum microRNA-135a downregulation as a prognostic marker of non-small cell lung cancer.
    Zhang YK; Sun B; Sui G
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27525941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B; Liu HF; Ding Y; Li Z
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3061-3066. PubMed ID: 29863251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.